249336 WWH pp01-pp25 03 07 2018 12:25 Page 02 Strategic Report Key Information Investment objective and policy Worldwide Healthcare Trust PLC is a specialist investment trust that invests in the global healthcare sector with the objective of achieving a high level of capital growth.
In order to achieve its investment objective, the Company invests worldwide in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector.
It uses gearing, and derivative transactions to enhance returns and mitigate risk.
Performance is measured against the MSCI World Health Care Index on a net total return, sterling adjusted basis Benchmark.
Further details of the Companys investment policy are set out in the Strategic Report on pages 6 and 7.
Accessing the global market The healthcare sector is global and accessing this market as a UK investor can be difficult.
Within the UK, there are diminishing options for investment as the universe of healthcare companies is shrinking through merger and acquisition activity.
The Company offers an opportunity to gain exposure to pharmaceutical, biotechnology and related companies in the healthcare sector on a global scale.
Worldwide Healthcare Trust PLC is able to participate in all aspects of healthcare, anywhere in the world because of its broad investment mandate.
These may include patented speciality medicines for small patient populations and unpatented generic drugs, in both developed countries and emerging markets.
In addition, the Company invests in medical device technologies, life science tools and healthcare services.
The overall geographic spread of Worldwide Healthcare Trust PLC is also extensive with investments in the U. S. Europe, Asia and emerging markets.
How to invest The Companys shares are traded openly on the London Stock Exchange and can be purchased through a stock broker or other financial intermediary.
The shares are available through savings plans including investment dealing accounts, ISAs, Junior ISAs and SIPPs which enable both regular monthly investments and lump sum investments in the Companys shares.
There are a number of investment platforms that offer these facilities.
Further details can be found on pages 75 and 76.
Total return performance since launch to 31 March 2018 % 3500 3000 2500 2000 1500 1000 500 0 WWH NAV per Share total return WWH Share Price total return Benchmark total return Rebased to 100 as at 28 April 1995 Source: Morningstar, Thomson Reuters & Bloomberg With effect from 1 October 2010, the performance of the Company is measured against the MSCI World Health Care Index on a net total return, sterling adjusted basis.
Prior to this date, performance was measured against the Datastream World Pharmaceutical & Biotechnology Index total return, sterling adjusted Worldwide Healthcare Trust PLC 02 Annual Report for the year ended 31 March 2018 Apr 95 Mar 96 Mar 97 Mar 98 Mar 99 Mar 00 Mar 01 Mar 02 Mar 03 Mar 04 Mar 05 Mar 06 Mar 07 Mar 08 Mar 09 Mar 10 Mar 11 Mar 12 Mar 13 Mar 14 Mar 15 Mar 16 Mar 17 Mar 18
